VR Logo

Syncom Formulations (India) Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1988

Chairman: Kedarmal Bankda

Managing Director: Vijay Shankarlal Bankda

Group: --

Listing: BSE: 524470

Headquarters: Mumbai, Maharashtra

Website: www.sfil.in

Key Facts

Market cap: R 73.38 Cr

Revenue (TTM): R 223.72 Cr

Earnings (TTM): R 12.95 Cr

Cash: R 7.87 Cr

Total Debt: R 8.76 Cr

Promoters' ownership: 40.14%

Liquidity: Moderate

52 Week range: R 0.39 - 1.36

Face value: R1.00

Shares outstanding: 78,06,52,180

10 Years Aggregate:

  • CFO: 44.89 Cr
  • EBITDA: 121.85 Cr
  • Net Profit: 73.48 Cr

Stock Performance

Time Period Syncom Formulations (India) S&P BSE Healthcare S&P BSE Small Cap
YTD25.3317.93-15.54
1 month-6.003.294.22
3 months42.4213.75-15.99
1 Year-16.8117.97-22.54
3 Years-17.574.50-8.90
5 Years-22.33-0.111.33
10 Years-0.5511.122.98
As on 03-Jun-2020
Year Syncom Formulations (India) S&P BSE Small Cap S&P BSE Healthcare
2019-18.48-6.85-3.55
2018-55.57-23.41-5.89
20170.0059.640.49
2016-54.981.77-12.88
2015-15.966.7615.06
2014-1.8369.2447.43
2013362.17-11.2322.55

Review & Analysis